Isofol Medical Investor Relations Material
Latest events
Investor Meeting
Isofol Medical
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Isofol Medical
Access all reports
Segment Data
Access more data
Revenue by
Geography
Asia
Expenses by
Financials
Isofol Medical operates as a clinical stage biotech company that develops and commercializes oncology drugs. Its products include arfolitixorin, which is in phase 3 clinical trial for the treatment of colorectal cancer; pentosan sulfate sodium, which has completed a phase 2 clinical trial for ovarian cancer or recurrent bladder cancer indication; new chemical entities, preclinical NCEs; monoclonal antibodies, which are being investigated for immunotherapy treatment of different types of cancer.
Key slides for Isofol Medical
Investor Meeting
Isofol Medical
Investor Meeting
Isofol Medical
Latest articles
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
ISOFOL
Country
🇸🇪 Sweden